Catalog No.
Product Name
Application
Product Information
Citations
-
Chikungunya Virus Polymerase Inhibitor
GAP-1173149 is a selective inhibitor of the Chikungunya virus (CHIKV) polymerase, specifically targeting the nsP4 RNA-dependent RNA polymerase. This compound demonstrates potent antiviral activity by hindering viral RNA replication, making it a valuable tool for studying CHIKV biology and developing antiviral strategies. Its application is particularly relevant in research focused on emerging viral threats and potential therapeutic interventions for Chikungunya virus infections. -
SIRT1 Inhibitor
SIRT1-IN-1 is a selective inhibitor of SIRT1, exhibiting an IC50 of 0.205 μM. In addition to its primary target, it also inhibits SIRT2 with an IC50 of 11.5 μM. This indole compound demonstrates antiviral activity, particularly against cytomegalovirus (CMV), making it a valuable tool for research into SIRT1-related pathways and antiviral applications. -
Viral DNA Polymerases Inhibitor
Cidofovir diphosphate is a potent inhibitor of viral DNA polymerases, primarily targeting human cytomegalovirus (HCMV), herpes simplex virus type 1 (HSV-1), and herpes simplex virus type 2 (HSV-2). With Ki values of 6.6 μM, 0.86 μM, and 1.4 μM for these polymers, respectively, it demonstrates selective antiviral activity. This compound is instrumental in research focusing on antiviral drug development and elucidating the mechanisms underlying viral DNA replication. -
Polymerase Inhibitor
T-1105 is a novel broad-spectrum viral polymerase inhibitor that acts by being converted into a ribonucleoside triphosphate (RTP) metabolite. This compound demonstrates antiviral activity against multiple RNA viruses by inhibiting their polymerases. T-1105 is particularly significant in studies aimed at understanding viral replication and developing antiviral strategies. Its mechanism of action highlights its potential applications in viral pathogenesis research and therapeutic interventions. -
SIRT Inhibitor
Nicotinamide hydrochloride is an inhibitor of SIRT1 and SIRT2, targeting the sirtuin family of proteins critical for cellular regulation. This reagent has been shown to enhance cellular levels of NAD+ and ATP while increasing reactive oxygen species (ROS) levels. Research applications include investigation into tumor growth inhibition and potential improvements in survival, as well as exploring its anti-hepatitis B virus (HBV) activity. -
HCV NS5B Polymerase Inhibitor
MB-11362 is a potent, orally active inhibitor of the hepatitis C virus (HCV) NS5B polymerase, functioning as a 4′-azidouridine triphosphate prodrug. Upon oral administration, MB-11362 is converted to its active form, 4′-azidouridine triphosphate, which effectively disrupts viral RNA synthesis. This compound is valuable for research focusing on HCV infection and understanding the mechanisms of antiviral therapies targeting RNA polymerases. -
Nucleoside Analog/Anti-HCV Agent
Valopicitabine dihydrochloride is a nucleoside analog that serves as the orally bioavailable prodrug of the potent anti-HCV agent 2'-C-methylcytidine. It functions by competitively inhibiting the NS5B polymerase, leading to chain termination and subsequent viral replication inhibition. This compound is primarily utilized in research related to Hepatitis C virus (HCV) treatment and antiviral drug development. -
HCV RNA Polymerase Inhibitor
BILB 1941 is a potent nonnucleoside inhibitor targeting the hepatitis C virus (HCV) RNA polymerase. It demonstrates significant antiviral activity in vitro, making it a valuable tool for research applications related to HCV replication and drug development strategies against hepatitis C. -
NS5B Polymerase Inhibitor
ABT-072 potassium trihydrate is a potent non-nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase. It demonstrates significant antiviral activity, exhibiting EC50 values of 1 nM against HCV genotype 1a and 0.3 nM against genotype 1b. This compound is primarily utilized in research focused on HCV replication and the development of antiviral therapies. -
Nucleoside Analog/Anti-HCV Agent
Valopicitabine is a nucleoside analog and an orally bioavailable prodrug of the potent anti-hepatitis C virus (HCV) agent 2'-C-methylcytidine. It selectively targets the NS5B polymerase, competitively inhibiting its activity and resulting in chain termination during viral RNA synthesis. Valopicitabine is primarily utilized in research focused on HCV infection and antiviral therapy development. -
HCV NS5B Polymerase Inhibitor
MK3281 is a non-nucleoside inhibitor targeting the hepatitis C virus (HCV) NS5B polymerase. It demonstrates significant antiviral activity, with an EC50 of 28 nM for genotype 1a. This compound is utilized in research focused on antiviral drug development and understanding HCV replication mechanisms. -
NS5B Polymerase Inhibitor
PSI-353661 is a purine nucleotide inhibitor targeting the NS5B polymerase of Hepatitis C Virus (HCV). It demonstrates potent antiviral activity with EC90 values of 8 nM for wild-type HCV and 11 nM for the S282T resistant strain. Additionally, PSI-353661 achieves elevated levels of its active triphosphate form in primary human hepatocytes, making it a valuable tool for studying HCV replication and resistance mechanisms. -
HCV NS5B Polymerase Inhibitor
HCV NS5B polymerase-IN-3 is a potent inhibitor of the hepatitis C virus (HCV) NS5B polymerase, demonstrating significant antiviral activity. In the Huh7 replicon cell line, it exhibits an EC50 value of 0.23 μM while maintaining a favorable cytotoxicity profile. This compound is relevant for research applications focused on HCV replication and drug development strategies targeting hepatitis C. -
HCV Polymerase Inhibitor
VCH-916 free base is a non-nucleoside inhibitor targeting the NS5B polymerase of Hepatitis C virus (HCV). This compound demonstrates potent antiviral activity, making it a valuable tool for research on HCV replication. It is primarily utilized in studies focused on developing effective treatments for Hepatitis C and understanding the viral mechanisms of polymerase function. -
DNA Gyrase/Topoisomerase IV Inhibitor
Topoisomerase Inhibitor 6 is a dual irreversible inhibitor targeting DNA gyrase and topoisomerase IV, demonstrating a minimum inhibitory concentration (MIC) of 0.06 μg/mL against fluoroquinolone-resistant Staphylococcus aureus. This compound functions by obstructing the DNA strand break-reunion process, thereby causing lethal DNA damage. It holds potential for the study of Gram-positive bacterial infections, including those caused by S. aureus and Streptococcus pneumoniae. -
Topoisomerase II Inhibitor
NBTI 5463 is an inhibitor of bacterial type II topoisomerases, specifically targeting topoisomerase II. This compound exhibits potent antibacterial activity by inhibiting GyrA and TopoIV in Pseudomonas aeruginosa and Escherichia coli. By binding to topoisomerase II, NBTI 5463 disrupts DNA cleavage and religation, thereby obstructing bacterial DNA replication and transcription. This compound holds promise for advancing research on Gram-negative bacterial infections. -
Topoisomerase II Inhibitor
(-)-BO 2367 is a potent topoisomerase II inhibitor, exhibiting significant antibacterial and antitumor properties. It demonstrates IC50 values of 3.8 μM against the DNA relaxation activity of L1210 topoisomerase II and 0.5 μM and 1 μM against the supercoiling activities of Escherichia coli and Micrococcus luteus gyrases, respectively. This compound is valuable for research applications in cancer biology and microbial resistance studies, facilitating further exploration of therapeutic interventions. -
Cytidine Analog
2',3',5'-Tri-O-benzoyl-5-azacytidine serves as a potent cytidine analog with a primary mechanism of inhibiting DNA methyltransferases. This compound demonstrates significant anti-metabolic and anti-tumor activities, making it a valuable tool in cancer research and epigenetic studies. Its ability to interfere with DNA methylation processes positions it as an important reagent for investigating gene expression regulation and therapeutic interventions in oncology. -
Unsaponifiable Lipid
4α-Methylfecosterol is an unsaponifiable lipid that serves as a critical component in lipid metabolism studies. This compound exhibits unique biological activity by influencing membrane fluidity and cellular signaling pathways. It is valuable for research applications in lipid biochemistry, endocrinology, and the study of metabolic disorders. -
Thymidine Analog
5-(Hydroxymethyl)-2′,3′-O-(1-methylethylidene)uridine is a thymidine analog that integrates into replicated DNA. This compound demonstrates insertional activity, making it valuable for cell labeling and monitoring DNA synthesis. Its applications extend to research focusing on cellular proliferation and genetic analysis. -
Cytidine Analog
5-Methoxy cytidine is a cytidine analog that functions primarily as an inhibitor of DNA methyltransferases. This compound exhibits potential anti-metabolic and anti-tumor activities, making it valuable in cancer research and epigenetics studies. Its unique properties enable investigations into the regulatory roles of DNA methylation in various biological processes and diseases. -
Nucleoside Analogue
1-(2,3,5-Tri-O-benzoyl-2-C-β-methyl-β-D-ribofuranosyl)-5-nitropyridine-2(1H)-one is a nucleoside analogue targeting cellular enzymatic pathways. This compound exhibits potential antiviral and anticancer activity, making it a valuable tool for researchers studying nucleoside metabolism and related therapeutic applications. Its unique structural modifications enhance its stability and efficacy in various biological systems, facilitating investigations into nucleoside function and biochemistry. -
Purine Nucleoside Analog
3',4-Dideoxyuridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanism involves the inhibition of DNA synthesis, leading to apoptosis in cancer cells. This compound is valuable for research applications focused on cancer biology and therapeutic interventions targeting nucleoside metabolism. -
Nucleoside Metabolite
5-(L-Alanin-3-yl)-2-hydroxy-cis,cis-muconate 6-semialdehyde is a nucleoside metabolite that plays a critical role in metabolic pathways. This compound exhibits notable biological activity related to nucleoside metabolism, making it valuable for research in cellular processes and enzymatic reactions. It is particularly useful for studies focused on nucleoside regulation and metabolism in various biological contexts. -
Purine Nucleoside Analog
1-Amino-7-cyclopropyl methyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analog that targets critical pathways in cancer cells. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as DNA synthesis inhibition and the induction of apoptosis. Its unique structural features make it a valuable tool in cancer research, particularly for investigating therapeutic strategies in lymphoid cancers. -
Nucleoside Metabolite
(R)-Ureidoisobutyric acid is a nucleoside metabolite that plays a crucial role in various biochemical processes. This compound serves as an important intermediate in nucleotide metabolism and is utilized in research focused on cellular signaling, metabolism, and nucleic acid biochemistry. Its ability to influence metabolic pathways makes it a valuable tool for exploring cellular functions and disease mechanisms. -
Purine Nucleoside Analog
2′-O-Methyl-2-amino-6-chloropurine riboside is a purine nucleoside analog that serves as an important tool in cancer research. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by interfering with DNA synthesis and inducing apoptosis in cancer cells. Its versatile applications in cellular and molecular biology make it a valuable reagent for studying therapeutic strategies against various malignancies. -
Guanosine Analog
2'-C-Methylguanosine is a guanosine analogue that primarily targets and activates Toll-like receptor 7 (TLR7). It exhibits significant immunostimulatory activity and has been shown to induce type I interferons in various animal models, leading to antiviral effects. This compound is valuable for research applications focused on exploring the immune response and antiviral mechanisms. -
Adenosine Analog
3'-β-C-Methyladenosine is an adenosine analog that primarily targets adenosine receptors. This compound exhibits biological activity as a smooth muscle vasodilator and has demonstrated potential in inhibiting cancer progression. It is useful in research applications focused on cardiovascular function and cancer biology. -
Purine Nucleoside Analog
4’-C-Methyl-4-deoxyuridine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. This compound primarily functions by inhibiting DNA synthesis and inducing apoptotic pathways in cancer cells. Its research applications include exploring mechanisms of cancer treatment and evaluating therapeutic efficacy in oncology studies. -
Nucleoside Metabolite
(R)-2-Hydroperoxy-α-linolenic acid is a nucleoside metabolite that plays a crucial role in fatty acid metabolism. It exhibits notable biological activities, including modulation of oxidative stress and cell signaling pathways. This compound is particularly useful in research focused on lipid metabolism, cell function, and the effects of oxidative damage in various biological systems. -
Purine Nucleoside Analog
2'-Deoxy-2'-fluoro-6-S-Methyl-6-thio-ara-guanosine is a purine nucleoside analog that primarily targets nucleotide metabolism. It exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, through mechanisms such as inhibition of DNA synthesis and the induction of apoptosis. This compound serves as a valuable tool in cancer research, facilitating the exploration of therapeutic strategies targeting purine metabolism. -
Purine Nucleoside Analog
5-Hydroxy-2'-O-methyluridine is a purine nucleoside analog that exhibits significant anticancer activity. This compound functions primarily by inhibiting DNA synthesis and inducing apoptosis in cancer cells, making it a valuable tool in research aimed at understanding treatments for indolent lymphoid malignancies. Its biological properties position it as a promising candidate for further investigation in cancer therapy development. -
Purine Nucleoside Analog
6-(2-O-Methyl-beta-D-ribofuranosyl)-3-(2-oxo-propyl)-6H-imidazo[1,2-c]pyrimidin-5-one is a purine nucleoside analog with promising antitumor activity against indolent lymphoid malignancies. Its cytotoxic effects primarily involve the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This compound's unique structure allows for further exploration in the development of targeted therapies for various malignancies. -
Nucleoside Metabolite
4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoic acid is a nucleoside metabolite that plays a significant role in cellular metabolism. This compound is implicated in various biochemical pathways, including those involving nucleobase metabolism. Its biological activities make it valuable for research applications focused on enzymatic reactions related to nucleoside synthesis and regulation. -
Purine Nucleoside Analog
3’-N-Acetyl-3’-amino-3’-deoxyuridine is a purine nucleoside analog primarily involved in inhibiting DNA synthesis. This compound exhibits potent antitumor activity, particularly against indolent lymphoid malignancies. Its mechanisms of action include inducing apoptosis and impairing cellular proliferation, making it a valuable reagent for cancer research and therapeutic studies. -
Nucleoside Metabolite
3-Benzylmalic acid is a nucleoside metabolite that serves as a valuable intermediate in biochemical synthesis. It can be produced from 2-Benzylmalic acid via a hydroxyl isomerization reaction catalyzed by HphCD. This compound is utilized in various research applications, particularly in studies related to enzymatic reactions and metabolic pathways involving nucleoside derivatives. -
Purine Nucleoside Analog
5′-O-[Bis(4-methoxyphenyl)phenylmethyl]cytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its biological action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool in cancer research. This compound is suitable for studying mechanisms of cancer cell proliferation and developing therapeutic strategies targeting nucleoside metabolism. -
Purine Nucleoside Analog
3’,5’-Di-O-acetyl-2’-deoxy-N3-methyl uridine is a purine nucleoside analog that acts primarily by inhibiting DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include induction of apoptosis and disruption of cellular proliferation, making it a valuable reagent for research in oncology and molecular biology. -
Purine Nucleoside Analog
3'-Azido-3'-deoxy-N6-methyladenosine is a purine nucleoside analogue designed for research applications in cancer biology. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies, by inhibiting DNA synthesis and inducing apoptosis. Additionally, it serves as a versatile click chemistry reagent, featuring an azide group that enables it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-containing molecules or DBCO/BCN-functionalized compounds, facilitating bioconjugation studies. -
Purine Nucleoside Analog
2′-Deoxy-2′-fluoro-N-methyladenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action includes the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is valuable for researchers investigating therapeutic strategies and mechanisms of action in cancer biology. -
Nucleoside Metabolite
2-Methyl-1-hydroxypropyl-ThPP is a nucleoside metabolite that plays a critical role in nucleoside metabolism. This compound is involved in various biological processes and is essential for studying cellular metabolism pathways. Its applications extend to research on nucleoside-related signaling and metabolic regulation in various biological systems. -
Purine Nucleoside Analog
N4-Ethyl-2’-deoxycytidine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. The compound functions primarily by inhibiting DNA synthesis, leading to the induction of apoptosis in cancer cells. Its applications in research include exploring mechanisms of cancer cell proliferation and evaluating therapeutic strategies targeting nucleosynthesis pathways. -
Quercetin Metabolite
3α,7α,12α,26-Tetrahydroxy-5β-cholestane is a significant metabolite of Quercetin, functioning as a key marker in primary bile acid biosynthesis. This compound plays a crucial role in research related to atherosclerosis, providing insights into lipid metabolism and cardiovascular health. Its biological activities make it a valuable reagent for studying the effects of dietary flavonoids on cellular pathways. -
Nucleoside Metabolite
(S)-Ureidoglycolic acid is a substrate for the enzyme ureidoglycolate dehydrogenase, playing a critical role in purine metabolism pathways. As a member of the n-carbomoyl-α-amino acid class, it is essential for studies focused on nucleotide biosynthesis and related metabolic processes. This compound serves as a valuable research tool for understanding the biochemical intricacies of purine metabolism and its implications in various physiological contexts. -
Nucleoside Metabolite
Phosphonoformyl-CMP is a nucleoside metabolite that serves as an analogue of cytidine monophosphate. This compound is primarily utilized in studies of nucleotide metabolism and enzymatic activity related to nucleoside triphosphate synthesis. Its unique structure allows for exploration of biochemical pathways and interactions involving nucleotides, thereby informing research in molecular biology and pharmacology. -
Purine Nucleoside Analog
2’-Chloro-N6-(4-trifluoromethyl)benzyl adenosine is a purine nucleoside analog that exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism of action involves the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable compound for cancer research. This reagent is suitable for studies focused on understanding tumor biology and developing therapeutic strategies targeting nucleoside pathways. -
Purine Nucleoside Analog
3'-Azido-3'-deoxy-5-trifluoromethyluridine is a purine nucleoside analogue primarily known for its broad antitumor activity against indolent lymphoid malignancies. Its anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis. Additionally, this compound serves as a click chemistry reagent, featuring an azide group that facilitates copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with alkyne-containing molecules, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN functionalized compounds. -
Purine Nucleoside Analog
5’-O-TBDPS-2,2’-anhydrouridine is a purine nucleoside analog that acts primarily by inhibiting DNA synthesis. This compound exhibits significant antitumor activity, particularly against indolent lymphoid malignancies. Its mechanism also includes the induction of apoptosis, making it a valuable tool for research focused on cancer biology and therapeutic development. -
Purine Nucleoside Analog
3-epi-Azido-3-deoxythymidine is a purine nucleoside analog known for its antitumor activity, particularly against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis, making it a valuable tool for cancer research. This reagent is suitable for studies exploring therapeutic strategies in oncology and the mechanistic understanding of tumor cell behavior.
